Influenza A+B Rapid Test
Rapid test for the qualitative detection of influenza A and B viruses in throat and nasal swabs as well as nasal secretion specimens. For professional in vitro diagnostic use only.
Influenza (also known as the “flu”) is an extremely infectious, acute viral infection of the respiratory tract. It is a disease that is transmitted by live viruses in airborne droplets. Influenza outbreaks occur annually, typically in the autumn and winter months. Type A viruses are generally more widespread than Type B viruses and cause the more serious influenza outbreaks. The gold standard of laboratory diagnosis is a 14-day cell culture with a variety of cell lines that support the growth of influenza viruses. The cell cultures are only of limited use in everyday clinical practice, as the results are achieved too late to initiate medical treatment. The reverse transcriptase polymerase chain reaction (RT-PCR) is a newer, more sensitive method than the culture, with an improved detection rate of 2-23% compared to the culture method. However, RT-PCR is expensive, complex and can only be performed in specialised labs. The RightSign Influenza A+B rapid test qualitatively detects influenza A and/or B antigens in nasal and throat swabs as well as nasal secretions and provides results within 15 minutes. For this purpose, influenza A and B-specific antibodies are used to detect influenza A or B antigens in the sampls
Materials Provided
Scientific & laboratory services. Sole agent of Zybio analyzers and exclusive agent of RightSign rapid tests in Egypt.
